Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chengyang Zou"'
Autor:
Mei-Yu Quan, Xihua Yan, Wanqi Miao, Xue Li, Jiaqi Li, Linglong Yang, Chenhua Yu, Yanxia Zhang, Weiwei Yang, Chengyang Zou, Bin Liu, Xuru Jin, Chengshui Chen, Qiang Guo, Jin-San Zhang
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 272, Iss , Pp 116094- (2024)
Exposure to benzo[a]pyrene (B[a]P) has been linked to lung injury and carcinogenesis. Airway epithelial cells express the B[a]P receptor AHR, so B[a]P is considered to mainly target airway epithelial cells, whereas its potential impact on alveolar ce
Externí odkaz:
https://doaj.org/article/2ac7bdaee21b4810a2cf03c45758c610
Autor:
Chao Zhang, Qiang Guo, Lifeng Chen, Zheming Wu, Xiao-Jian Yan, Chengyang Zou, Qiuxue Zhang, Jiahong Tan, Tian Fang, Qunxian Rao, Yang Li, Shizhen Shen, Min Deng, Liewei Wang, Huanyao Gao, Jia Yu, Hu Li, Cheng Zhang, Somaira Nowsheen, Jake Kloeber, Fei Zhao, Ping Yin, Chunbo Teng, Zhongqiu Lin, Kun Song, Shuzhong Yao, Liangqing Yao, Lingying Wu, Yong Zhang, Xiaodong Cheng, Qinglei Gao, Jian Yuan, Zhenkun Lou, Jin-San Zhang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-17 (2023)
Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors are one of the most exciting classes of targeted therapy agents for cancers with homologous recombination (HR) deficiency. However, many patients without apparent HR defects also respond well to
Externí odkaz:
https://doaj.org/article/cca68174bd0f4c47bca6a90059d0f268
Autor:
Lixiao Liu, Jinduo Zhao, Xuedan Du, Ye Zhao, Chengyang Zou, Heling Zhou, Wenfeng Li, Xiaojian Yan
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 9097-9114 (2021)
Abstract Background Ovarian cancer (OC) is the most lethal gynecological malignancy. The objective of this study was to establish and validate an individual aging‐related gene signature and a clinical nomogram that can powerfully predict independen
Externí odkaz:
https://doaj.org/article/861a899c6ff94acab2fadb1cf98f1095
Autor:
Jinduo Zhao, Yong Guo, Xuedan Du, Wenfeng Li, Ye Zhao, Lixiao Liu, Jintao Fang, Chengyang Zou, Xiao-Jian Yan
Publikováno v:
Journal of Inflammation Research
Lixiao Liu,1,* Xuedan Du,2,* Jintao Fang,3,* Jinduo Zhao,1 Yong Guo,3 Ye Zhao,1 Chengyang Zou,1 Xiaojian Yan,1 Wenfeng Li2 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhe
Autor:
Piaopiao Ye, Chunhong Zhang, Jinduo Zhao, Wenfeng Li, Xuedan Du, Xiaojian Yan, Luya Cai, Chengyang Zou, Ye Zhao, Lixiao Liu, Shanshan Yu, Xiaoping Su
Publikováno v:
International Immunopharmacology. 101:108302
Cervical cancer is the fourth most common malignant tumor in the world, for advanced cervical cancer, more than 30% of patients continue to have tumor and relapse or metastasis after the traditional treatment (concurrent chemoradiotherapy), and the r